Back to Top
Enews Now
January 2018
In the News
Updated Practice Parameter on Influenza Vaccine for Egg Allergic Patients Published

The AAAAI/ACAAI Joint Task Force on Practice Parameters has published “Administration of influenza vaccines to egg allergic recipients: A practice parameter update 2017."
News Briefs
Boxed Warning on Asthma-Related Death Removed from Drugs Containing LABAs and ICS
The FDA is removing the asthma-related death warning from drugs with long-acting beta agonists (LABAs) and inhaled corticosteroids (ICS). Read more »
Check Out the New, Interactive Course on Allergen Immunotherapy
Practice effective allergen immunotherapy treatment with our new, free course involving a virtual patient. Read more »
Find Your Niche at Sessions Held before the Joint Congress
Attend sessions focusing on eosinophilic disorders, pollen and fungal spore identification, or join a literature review, all before the Joint Congress begins. Read more »
Web Tips

New Patient Education Videos Available on the AAAAI Website

The new videos in the Conditions & Treatments section of the AAAAI website are an excellent resource for your patients. They can listen to AAAAI experts discuss a variety of topics including skin allergies, food protein-induced enterocolitis syndrome and asthma. Here is the complete list of new videos:

  • What is a skin allergy?
  • Peanuts, tree nuts and coconuts: Not all nuts are created equal.
  • What are the pitfalls of food allergy panel testing?
  • What is food protein-induced enterocolitis syndrome (FPIES)?
  • What is chronic urticaria and dermatographism?
  • What is a latex allergy?
  • Could your persistent cough be asthma?
  • The true health effects from gluten: Celiac vs. wheat allergy vs. non-celiac gluten intolerance.

What Is a Lupin Allergy?

Your patients may be hearing more about lupin as an emerging food allergy. A new article in the Conditions & Treatments Library talks about symptoms, the link between peanuts and lupins, diagnosis, management, what products may contain lupin and how to read labels for lupin. This article is available in both English and Spanish.

From the President

Dear Colleagues,

An important meeting takes place each year in January: the Program Directors Assembly Winter Meeting, cosponsored by the AAAAI and the American College of Allergy, Asthma & Immunology (ACAAI). I had the privilege of attending the 2018 Winter Meeting, which was held this past weekend in Atlanta.

The Winter Meeting provides the program directors with an invaluable opportunity to tackle, as a group, important issues facing our allergy/immunology (A/I) training programs. These include current and emerging Accreditation Council for Graduate Medical Education (ACGME) requirements and initiatives, as well as innovative ways to educate our fellows-in-training (FITs). It also offers the program directors a forum to network with colleagues along with national leaders and representatives from the AAAAI, ACAAI, the American Board of Allergy and Immunology (ABAI) and ACGME.

Allow me to pause for a moment and acknowledge that we should all be extremely appreciative of the work the program directors do. They are responsible for overseeing our pipeline of trainees who will become the A/I professionals of the future. Our program directors are dedicated to teaching our FITs the skills and competencies necessary for them to become well-equipped allergist/immunologists, able to diagnose, treat and manage allergies, asthma and immunologic disorders. The outlook for our specialty would be bleak if we did not have competent FITs graduating from our programs each year and entering the field—whether in practice or the research setting—to become the next generation of allergist/immunologists.

As an aside concerning the future of our specialty, we continue to move forward on outcomes from the Summit for the Future of Allergy and Immunology, held back in October as part of my presidential initiatives.